Treatment of neuroblastoma cell lines with the specific WIP1-inhibitor SL-176 achieved complete inhibition with IC50 values within a rather narrow range of 0.57–1.3 μM, regardless of p53 or MDM2 status (Figure 4A, Figure S3A and Table S2A). Here, MDM2 is linked to neuroblastoma.